Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

Apr 21, 2020

SELL
$24.87 - $38.56 $385,808 - $598,181
-15,513 Closed
0 $0
Q4 2019

Feb 03, 2020

BUY
$25.43 - $36.67 $3,763 - $5,427
148 Added 0.96%
15,513 $562,000
Q3 2019

Oct 10, 2019

BUY
$23.0 - $27.97 $353,395 - $429,759
15,365 New
15,365 $418,000

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Juncture Wealth Strategies, LLC Portfolio

Follow Juncture Wealth Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Juncture Wealth Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Juncture Wealth Strategies, LLC with notifications on news.